全球精准医疗市场按应用、技术和地区划分

2025 年全球精准医疗市场规模预估为 1,029.3 亿美元，预计到 2032 年将达到 2,206.8 亿美元，2025 年至 2032 年的复合年增长率为 11.5%。

数字。 2025 年精准医疗市场占有率（%），依地区划分

精准医疗是一种考虑到基因、环境和生活方式的个体差异的疾病治疗和预防新方法。这种方法将使医生和研究人员能够更准确地预测哪些针对特定疾病的治疗和预防策略适用于哪些群体。这与「一刀切」的方法相反，在「一刀切」的方法中，对每个人的疾病都采用标准方式治疗。精准医疗整合遗传讯息和分子诊断，根据每位患者的个人特征制定治疗方案。了解更多有关患者的基因组成可以帮助医生确定某些药物、生活方式的改变或治疗是否有效，或者是否应该针对每个人考虑不同的选择。这使得研究人员和医疗保健提供者能够确定每位患者最安全的治疗方法，从而改善治疗效果。随着不断的研究和开发，精准医疗有望透过有针对性的疾病预防和治疗来改变医疗保健。

市场动态：

全球精准医疗市场受到个人化医疗需求不断增长、精准治疗药物研发投入增加、次世代定序仪（NGS）在精准医疗中的应用不断扩大、以及医疗储蓄需求激增的驱动。然而，缺乏资料解释和标准化以及治疗成本的上升预计会抑制市场的成长。另一方面，新兴国家为市场公司提供了高成长机会。与传统治疗方法相比，精准医疗方法可以透过提供具有更高疗效和更少副作用的标靶治疗来帮助解决多项快速成长的医疗挑战。伴同性诊断的日益采用以及精准医疗纳入药物开发活动也带来了新的机会。

本研究的主要特点

• 本报告对全球精准医疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和復合年增长率。
• 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
• 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
• 全球精准医疗市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 全球精准医疗市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员将透过用于分析全球精准医疗市场的各种策略矩阵来促进其决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 限制因素
• 市场机会
• 影响分析
• 市场趋势
• 收购和合作场景
• 持续发展
• 波特的分析
• PEST分析

第四章 全球精准医疗市场：COVID-19 疫情的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

第 5 章。全球精准医疗市场依技术划分（2020-2032 年）

• 生物资讯学
• 基因序列分析
• 药物研发
• 精准分子诊断
• 巨量资料分析

第六章 全球精准医疗市场依应用划分（2020 年至 2032 年）

• 肿瘤学
• 中枢神经系统
• 血液学
• 免疫学
• 呼吸系统
• 其他的

第七章 全球精准医疗市场依地区划分（2020-2032）

• 各地区市场占有率分析：2025 年及 2032 年（%）
• 各地区较去年与前一年同期比较成长分析
• 区域趋势
• 北美洲
  • 市场规模及各技术预测、年成长与前一年同期比较
  • 市场规模及应用预测、年成长与前一年同期比较
  • 各国市场规模及预测、年成长与前一年同期比较
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲国家
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 北非
  • 中部非洲
  • 南非

第八章 竞争格局

• Intomics
• GENinCode
• NanoString
• Tepnel Pharma Services Limited
• Pfizer Inc.
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc
• QIAGEN
• Quest Diagnostics Incorporated
• Medtronic
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• bioMerieux SA
• F. Hoffmann-La Roche Ltd
• Eli Lilly & Company
• GlaxoSmithKline plc
• Cepheid
• AstraZeneca PLC
• Myriad Genetics, Inc.
• Bristol-Myers Squibb Company

第 9 章分析师观点

• 命运之轮
• 分析师观点
• Coherent Opportunity Map（COM）

第十章参考文献与调查方法

• 参考
• 调查方法

Global Precision Medicine Market is estimated to be valued at USD 102.93 Bn in 2025 and is expected to reach USD 220.68 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.

Figure. Precision Medicine Market Share (%), By Region 2025

Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. This approach allows doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a ""one-size-fits-all"" approach, where disease treatment is a standardized approach for all people. Precision medicine integrates genetic information and molecular diagnostics to tailor medical treatments based on the individual characteristics of each patient. With greater knowledge of patients' genetic makeup, doctors can determine if certain medicines, lifestyle changes, or treatments will help or if different options may need to be considered depending on the individual. This allows researchers and healthcare providers to determine the safest treatment option tailored for each patient, leading to improved treatment outcomes. With continued research and development, precision medicine holds promise to transform healthcare through targeted disease prevention and treatment.

Market Dynamics:

The global precision medicine market is driven by the increasing demand for personalized healthcare, rise in R&D investments for precision therapeutics development, growing application of next-generation sequencing (NGS) in precision medicine, and surging demand for healthcare reduction. However, the lack of data interpretation & standardization and high cost of treatment are expected to restrain the market growth. Meanwhile, emerging economies offer high-growth opportunities for market players. Precision medicine approaches could help address several burgeoning healthcare challenges by offering targeted therapeutics with improved efficacy and reduced side-effects compared to conventional treatment methods. The growing adoption of companion diagnostics and inclusion of precision medicine in drug development activities also presents new opportunities.

Key Features of the Study:

• This report provides an in-depth analysis of the global precision medicine market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global precision medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMerieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics Inc., and Bristol-Myers Squibb Company
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global precision medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global precision medicine market.

Market Segmentation

• Technology:
  • Bioinformatics
  • Gene Sequencing
  • Precision Molecular Diagnostics
  • Big Data Analytics
  • Others
• Application:
  • Oncology
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
  • Central Nervous System
  • Hematology
  • Immunology
  • Respiratory
  • Others
• End User:
  • Biopharmaceutical Companies
  • Diagnostic Laboratories
  • Academic & Research Institutions
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Intomics
  • GENinCode
  • NanoString
  • Tepnel Pharma Services Limited
  • Pfizer Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co. Inc
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Medtronic
  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • bioMerieux SA
  • Hoffmann-La Roche Ltd
  • Eli Lilly & Company
  • GlaxoSmithKline plc
  • Cepheid
  • AstraZeneca PLC
  • Myriad Genetics Inc.
  • Bristol-Myers Squibb Company

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Market Trends
• Acquisitions and Partnerships Scenario
• Ongoing Developments
• Porter's Analysis
• PEST Analysis

4. Global Precision Medicine Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Precision Medicine Market, By Technology, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Bioinformatics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Gene Sequencing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Drug Discovery
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Precision Molecular Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Big Data Analytics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Precision Medicine Market, By Application, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Oncology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
• Central Nervous System
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Hematology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Immunology
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Respiratory
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Precision Medicine Market, By Region, 2020 - 2032, (US$ Billion)

• Introduction
• Market Share Analysis, By Region, 2025 and 2032 (%)
• Y-o-Y Growth Analysis, For Regions, 2020-2032
• Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • UK
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

• Intomics
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• GENinCode
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NanoString
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Tepnel Pharma Services Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc
• QIAGEN
• Quest Diagnostics Incorporated
• Medtronic
• Thermo Fisher Scientific Inc.
• Laboratory Corporation of America Holdings
• bioMerieux SA
• F. Hoffmann-La Roche Ltd
• Eli Lilly & Company
• GlaxoSmithKline plc
• Cepheid
• AstraZeneca PLC
• Myriad Genetics, Inc.
• Bristol-Myers Squibb Company

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact